国药现代(600420.SH)上半年净利润6.72亿元，同比下降6.46%

Core Viewpoint - The company reported a decline in both revenue and net profit for the first half of 2025 compared to the previous year [1] Financial Performance - The company achieved operating revenue of 4.878 billion yuan, a year-on-year decrease of 18.16% [1] - The net profit attributable to shareholders of the listed company was 672 million yuan, down 6.46% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 637 million yuan, reflecting a year-on-year decline of 6.77% [1] - Basic earnings per share were reported at 0.5011 yuan [1]